Nightmare comorbid with insomnia
Conditions
Interventions
A group: Arm A consists of digital CBT-I + IRT, which is designed to incorporate elements from both therapies and comprises 6 weekly modules. Based on the previous research and aligning with the recom
B group:Arm B consists of digital CBT-I only, which mirrors solely the CBT-I components of the Arm A treatment program
C group:Arm C is a waitlist control group, consisting of a 6-week waiting period.
Sponsors
The Chinese University of Hong Kong
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Adults who meet all the following criteria will be eligible to study: 1. Adults aged between 18–65 years old 2. Sufficient fluency in Cantonese to participate in psychotherapy, complete questionnaires and provide written consent 3. Meeting DSM-5 (Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition) criteria for insomnia disorder 4. Having nightmares at least once a week for at least one month.
Exclusion criteria
Exclusion criteria: Adults who meet one or more of the following criteria will be excluded from the study: 1. Diagnosed with current PTSD, psychosis, bipolar disorder, intellectual disability, substance abuse, or moderate to high suicidality, as rated in Structured clinical interview for DSM-5 (SCID-5) 2. Diagnosed with untreated sleep disorders, such as sleep apnea, restless legs syndrome, narcolepsy or parasomnia. 3. Currently using medications that may interfere with sleep and dreaming. 4. Having current psychotherapy may interfere with the efficacy of IRT or CBT-I.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nightmare Distress Questionnaire (NDQ);Insomnia severity index (ISI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Nightmare Frequency Questionnaire (NFQ);Nightmare Disorder Index (NDI);Nightmare Effect Survey (NES);Prospective 7-day dream diary;Prospective 7-day sleep diary;Prospective 7-day actigraphy;Polysomnography (PSG);Patient health questionnaire-9 (PHQ-9);Generalized anxiety disorder-7 (GAD-7);World Health Organization quality of life - abbreviated version (WHOQOL-BREF);Epworth sleepiness scale (ESS);Multidimensional fatigue inventory (MFI);Morningness/eveningness questionnaire-5 items (MEQ-5);Hospital Anxiety and Depression Scale (HADS);The Connor-Davidson Resilience Scale (CDRS-10); | — |
Countries
China
Contacts
Public ContactChan Ngan Yin
The Chinese University of Hong Kong
Outcome results
None listed